Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Venugopalan · SciRah

Researcher profile · Semantic Scholar

A. Venugopalan

Share profile

A. Venugopalan — researcher profile on SciRah

h-index: 10
Works: 26
Citations: 581

Most-cited papers

Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer
N. Roper, Anna L. Brown, Jun S. Wei, S. Pack +27 more
2020Cell Reports Medicine180 citations Open access
Semantic Scholar
APOBEC Mutagenesis and Copy-Number Alterations Are Drivers of Proteogenomic Tumor Evolution and Heterogeneity in Metastatic Thoracic Tumors
N. Roper, Shao-Jian Gao, Tapan K. Maity, A. R. Banday +17 more
2019Cell Reports100 citations Open access
Semantic Scholar
Loss of Mig6 accelerates initiation and progression of mutant epidermal growth factor receptor-driven lung adenocarcinoma
T. Maity, A. Venugopalan, I. Linnoila, C. Cultraro +13 more
2015Cancer Discovery68 citations Open access
Semantic Scholar
Identifying novel targets of oncogenic EGF receptor signaling in lung cancer through global phosphoproteomics
Xu Zhang, N. Belkina, Harrys K. C. Jacob, T. Maity +7 more
2015Proteomics44 citations Open access
Semantic Scholar
Development of highly effective anti-mesothelin hYP218 Chimeric Antigen Receptor T cells with increased tumor infiltration and persistence for treating solid tumors
R. Hassan, S. Tomar, Jing-Li Zhang, M. Khanal +8 more
2022Molecular Cancer Therapeutics43 citations Open access
Semantic Scholar
Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response*
Xu Zhang, T. Maity, M. Kashyap, M. Bansal +15 more
2017Molecular & Cellular Proteomics43 citations Open access
Semantic Scholar
EGFR-targeted therapy results in dramatic early lung tumor regression accompanied by imaging response and immune infiltration in EGFR mutant transgenic mouse models
A. Venugopalan, Min-Jung Lee, Gang Niu, J. Medina-Echeverz +7 more
2016OncoTarget30 citations Open access
Semantic Scholar
Genomic profiling of multiple sequentially acquired tumor metastatic sites from an “exceptional responder” lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment response
Romi Biswas, Shao-Jian Gao, C. Cultraro, T. Maity +21 more
2016Cold Spring Harbor molecular case studies21 citations Open access
Semantic Scholar
SCAMP3 is a mutant EGFR phosphorylation target and a tumor suppressor in lung adenocarcinoma
A. Venugopalan, Matthew Lynberg, C. Cultraro, K. Nguyen +6 more
2021Oncogene16 citations Open access
Semantic Scholar
Quantitative Mass Spectrometry to Interrogate Proteomic Heterogeneity in Metastatic Lung Adenocarcinoma and Validate a Novel Somatic Mutation CDK12-G879V*
Xu Zhang, K. Nguyen, P. Rudnick, N. Roper +9 more
2018Molecular & Cellular Proteomics13 citations Open access
Semantic Scholar
Persistence of activated anti‐mesothelin hYP218 chimeric antigen receptor T cells in the tumour is associated with efficacy in gastric and colorectal carcinomas
Sameer Mir, A. Venugopalan, Jingli Zhang, N. Nair +5 more
2024Clinical and Translational Medicine10 citations Open access
Semantic Scholar
Alterations in HLA Class I-Presented Immunopeptidome and Class I-Interactome upon Osimertinib Resistance in EGFR Mutant Lung Adenocarcinoma
Yue A. Qi, T. Maity, Shao-Jian Gao, Tao Gong +4 more
2021Cancers9 citations Open access
Semantic Scholar
Novel CDK12/13 Inhibitors AU-15506 and AU-16770 Are Potent Anti-Cancer Agents in EGFR Mutant Lung Adenocarcinoma with and without Osimertinib Resistance
Tapan K. Maity, Eun Young Kim, C. Cultraro, A. Venugopalan +8 more
2023Cancers4 citations Open access
Semantic Scholar
Abstract LB-A007: Non-viral site-directed hYP218 CAR T cells for mesothelin-expressing solid tumors
Sameer Mir, A. Venugopalan, Yosef A. Charkatli, R. Chari +2 more
2026Cancer immunology research0 citations
Semantic Scholar
Engineering Next-Generation Mesothelin CAR-T cells by Harnessing Naïve and Early Memory T cells
H. W. Song, A. Venugopalan, M. Procházková, S. Sarkar +5 more
2025Cytotherapy0 citations
Semantic Scholar
Abstract 62: Intra-tumor persistence of activated anti-mesothelin hYP218 CAR T cells is associated with increased efficacy in gastric and colorectal cancers
S. Mir, A. Venugopalan, Jing-Li Zhang, M. Khanal +4 more
2024Cancer Research0 citations
Semantic Scholar
Epigenetic Reprogramming Driven By Metabolic Alterations As A Mechanism Of EGFR – Tyrosine Kinase Inhibitor Resistance In Human Lung Adenocarcinoma
A. Venugopalan, K. Nguyen, Matthew Lynberg, T. Maity +11 more
2020The FASEB Journal0 citations Open access
Semantic Scholar
Abstract 4528: Quantitative mass spectrometry to interrogate proteomic heterogeneity in metastatic lung adenocarcinoma and validate a novel somatic mutation CDK12-G879V
X. Xhang, K. Nguyen, P. Rudnick, N. Roper +9 more
2019Cancer Chemistry0 citations
Semantic Scholar
Clonal evolution and osimertinib resistance mechanisms identified by whole exome and transcriptome sequencing in EGFR mutant NSCLC.
N. Roper, Anna L. Brown, Sivasish Sindiri, C. Cultraro +13 more
2019Journal of Clinical Oncology0 citations
Semantic Scholar
Integrated proteogenomic analysis of metastatic thoracic tumors identifies APOBEC mutagenesis and copy number alterations as drivers of proteogenomic tumor evolution and heterogeneity
N. Roper, Shao-Jian Gao, Tapan K. Maity, A. R. Banday +16 more
2018bioRxiv0 citations Open access
Semantic Scholar
Abstract A182: Apobec-mutagenesis drives mutational heterogeneity while copy number alterations drive transcriptomic and proteogenomic heterogeneity in metastatic lung adenocarcinoma and thymic carcinoma
N. Roper, James Gao, Rouf Banday, T. Maity +15 more
20180 citations
Semantic Scholar
P1.02-063 Tumor Heterogeneity Analyzes by Integrated Proteo-Genomics of Thoracic Tumors from Sequential Biopsies and Warm Autopsies
N. Roper, Xu Zhang, T. Maity, Shao-Jian Gao +12 more
20170 citations Open access
Semantic Scholar
Rapid/warm autopsy to reveal APOBEC-mutagenesis as driver of heterogeneity of metastatic thoracic tumors.
N. Roper, T. Maity, Shao-Jian Gao, A. Venugopalan +12 more
20170 citations
Semantic Scholar
Abstract 2927: Proteogenomic heterogeneity in metastatic lung adenocarcinoma revealed from rapid/warm autopsy
N. Roper, T. Maity, James Gao, A. Venugopalan +7 more
20170 citations Open access
Semantic Scholar
Abstract 5260: Identification of substrates of lung cancer-specific mutant EGFR kinases.
T. Maity, Hee-Sool Rho, Natalya Belinka, Zhi Xie +6 more
20130 citations
Semantic Scholar
Abstract 725: In vivo imaging and quantitative proteomics to study responsiveness to EGFR targeted therapy.
A. Venugopalan, N. Gang, Jinxia Guo, T. Maity +4 more
20130 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

U. Guha×20
Invite
U. Guha — researcher profile on SciRah
C. Cultraro×19
Invite
C. Cultraro — researcher profile on SciRah
T. Maity×16
Invite
T. Maity — researcher profile on SciRah
Xu Zhang×15
Invite
Xu Zhang — researcher profile on SciRah

×13

Invite

Romi Biswas — researcher profile on SciRah

Invite

N. Roper — researcher profile on SciRah

Shao-Jian Gao×11

Invite

Shao-Jian Gao — researcher profile on SciRah

Invite

Javed Khan — researcher profile on SciRah

Invite

A. Rajan — researcher profile on SciRah

Invite

S. Hewitt — researcher profile on SciRah

Sivasish Sindiri×5

Invite

Sivasish Sindiri — researcher profile on SciRah

Anish Thomas×5

Invite

Anish Thomas — researcher profile on SciRah